Clearstead Advisors’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.3K Buy
+725
New +$87.8K ﹤0.01% 1370
2026
Q1
Sell
-12
Closed -$2.09K 2544
2025
Q4
$2.09K Sell
12
-21
-64% -$3.83K ﹤0.01% 2137
2025
Q3
$4.75K Sell
33
-574
-95% -$70.3K ﹤0.01% 2173
2025
Q2
$61.1K Buy
607
+189
+45% +$14.5K ﹤0.01% 1224
2025
Q1
$31.9K Hold
418
﹤0.01% 1286
2024
Q4
$28.9K Sell
418
-57
-12% -$4.11K ﹤0.01% 1289
2024
Q3
$34.7K Buy
475
+326
+219% +$24.1K ﹤0.01% 1288
2024
Q2
$9.98K Buy
+149
New +$5.78K ﹤0.01% 1550

Other funds holding INSM

Clearstead Advisors's INSM Position: Q2 2026 in Review

Clearstead Advisors opened a new position in Insmed (INSM) in Q2 2026: 725 shares worth $77.3K. The stake represents ﹤0.01% of the portfolio and ranks #1370 among its holdings. This is a return to the name: Clearstead Advisors previously reported a position in INSM as recently as Q4 2025.

Clearstead Advisors first reported a position in INSM in Q2 2024 and has held it in 8 quarters since. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Clearstead Advisors held 725 shares of Insmed worth $77.3K as of Q2 2026.
  • Insmed was a new Clearstead Advisors position in Q2 2026.
  • Insmed made up ﹤0.01% of Clearstead Advisors's portfolio in Q2 2026, its #1370 holding.
  • Clearstead Advisors first reported a position in Insmed in Q2 2024 and has held it in 8 quarters since.
  • 666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.